See also this year's filing and all EDGAR filings for this company.
PDF Report 0000907654_2012_Oruka_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Excluding company: variable exceeds outlier threshold | pre-agg | {'variable': 'Expenses', 'value': 97304000, 'size_variable': 'Assets', 'size_value': 3212000, 'ratio': 30.3, 'threshold': 20} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000907654')"} |
Graph
Absolute values for 0000907654, Oruka Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesNoncurrent | 0 |
| 1 | LiabilitiesCurrent | 754,000 |
| 2 | remainder_Liabilities | 16,000 |
| 3 | AssetsCurrent | 6,212,000 |
| 4 | AssetsNoncurrent | 224,000 |
| 5 | PropertyPlantAndEquipmentNet | 66,000 |
| 6 | Goodwill | 0 |
| 7 | remainder_Assets | 0 |
| 8 | GeneralAndAdministrativeExpense | 39,356,000 |
| 9 | ResearchAndDevelopmentExpense | 41,585,000 |
| 10 | remainder_Expenses | 12,041,000 |
| 11 | remainder_Revenues | 2,026,000 |
| 12 | remainder_NetIncome | 27,282,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 770,000 |
| 1 | Assets | 6,502,000 |
| 2 | Expenses | 92,982,000 |
| 3 | Revenues | 2,026,000 |
| 4 | StockholdersEquity | 5,732,000 |
| 5 | NetIncome | -63,674,000 |
| 6 | ComprehensiveNetIncome | -63,674,000 |
| 7 | BaseVar | 64,781,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -15.4 |
| 9 | EconomicCapitalRatio | 0.0000000000000000000000152 |
Edgar->Model Mapping
Feature Distribution
